Profile data is unavailable for this security.
About the company
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. Its second prescription drug licensed product in its portfolio is Xepi, which is a topical non-fluorinated quinolone that inhibits bacterial growth and used for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.
- Revenue in USD (TTM)35.24m
- Net income in USD-13.51m
- Incorporated2015
- Employees85.00
- LocationBiofrontera Inc120 Presidential Way,, Suite 330WOBURN 01801United StatesUSA
- Phone+1 (781) 245-1325
- Fax+1 (302) 655-5049
- Websitehttps://www.biofrontera-us.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Processa Pharmaceuticals Inc | 0.00 | -10.22m | 4.62m | 13.00 | -- | 0.6763 | -- | -- | -5.36 | -5.36 | 0.00 | 2.10 | 0.00 | -- | -- | 0.00 | -115.58 | -84.35 | -133.48 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0016 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| GT Biopharma Inc | 0.00 | -11.35m | 4.87m | 2.00 | -- | 0.8845 | -- | -- | -7.72 | -7.72 | 0.00 | 2.47 | 0.00 | -- | -- | 0.00 | -82.84 | -205.36 | -120.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
| CYANOTECH CORP | 23.82m | -5.10m | 4.87m | 77.00 | -- | 0.4563 | -- | 0.2045 | -0.7549 | -0.7549 | 3.56 | 1.53 | 0.8895 | 2.05 | 12.12 | 309,389.60 | -19.04 | -3.46 | -29.60 | -4.46 | 24.72 | 34.54 | -21.41 | -3.58 | 0.3354 | -6.61 | 0.377 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
| AgriFORCE Growing Systems Ltd | 57.60k | -15.05m | 4.91m | 7.00 | -- | 0.3873 | -- | 85.17 | -5.81 | -5.81 | 0.0037 | 0.1343 | 0.0034 | -- | 1.21 | 8,228.57 | -88.79 | -78.95 | -124.14 | -109.86 | 17.86 | -- | -26,121.49 | -243,182.50 | 1.24 | -1.28 | 0.0789 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 5.17m | 4.00 | -- | 1.30 | -- | 1,293.64 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonnet Biotherapeutics Holdings Inc | 55.89k | -7.99m | 5.20m | 12.00 | -- | 1.99 | -- | 93.08 | -3.02 | -3.02 | 0.0144 | 0.5017 | 0.0071 | -- | 0.0881 | 4,657.50 | -100.88 | -- | -255.30 | -- | -- | -- | -14,287.67 | -- | -- | -331.07 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
| Cannapharmarx Inc | 25.84k | 627.24k | 5.83m | 21.00 | -- | -- | 8.39 | 225.62 | -0.0061 | -0.0061 | 0.00006 | -0.0254 | 0.003 | -- | 0.1654 | 1,230.48 | 7.36 | -131.06 | -- | -- | -1,692.76 | -- | 2,427.40 | -- | 0.0123 | -0.2483 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Integrated BioPharma, Inc. | 50.57m | -116.00k | 6.77m | 141.00 | -- | 0.3578 | 31.92 | 0.1338 | -0.0041 | -0.0041 | 1.67 | 0.6283 | 1.88 | 4.45 | 10.76 | 358,617.00 | -0.431 | 15.54 | -0.5698 | 28.00 | 7.09 | 12.09 | -0.2294 | 6.45 | 1.02 | -9.00 | 0.001 | -- | -9.91 | 3.00 | -100.42 | -- | -14.03 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -16.14m | 6.97m | 5.00 | -- | -- | -- | -- | -0.5143 | -0.5143 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -284.35 | -37.29 | -709.12 | -38.23 | -- | -- | -- | -- | -- | -- | 1.22 | -- | -- | -- | 43.40 | -- | -- | -- |
| Hoth Therapeutics Inc | 0.00 | -7.46m | 6.97m | 2.00 | -- | 0.5795 | -- | -- | -1.69 | -1.69 | 0.00 | 1.74 | 0.00 | -- | -- | 0.00 | -67.99 | -157.07 | -76.33 | -177.32 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
| Biofrontera Inc | 35.24m | -13.51m | 7.15m | 85.00 | -- | 0.6023 | -- | 0.2029 | -5.29 | -5.29 | 12.12 | 2.14 | 1.21 | 1.97 | 7.27 | 414,623.50 | -46.20 | -- | -113.24 | -- | 47.75 | -- | -38.33 | -- | 1.46 | -3.53 | 0.0264 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 7.20m | 96.00 | 0.3633 | 0.06 | 1.31 | 0.2438 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| CV Sciences Inc | 15.85m | -2.53m | 8.31m | 42.00 | -- | 3.31 | -- | 0.5244 | -0.0157 | -0.0157 | 0.098 | 0.0139 | 1.69 | 1.55 | 25.35 | 377,285.70 | -26.94 | -43.42 | -73.44 | -77.75 | 46.06 | 51.81 | -15.95 | -45.68 | 0.2530 | -- | 0.0114 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Bioquest Corp | 0.00 | -507.41k | 8.61m | -- | -- | -- | -- | -- | -0.0485 | -0.0485 | 0.00 | -0.0467 | 0.00 | -- | -- | -- | -3,483.76 | -- | -- | -- | -- | -- | -- | -- | -- | -3.88 | -- | -- | -- | -- | 64.67 | -- | -- | -- |
Data as of Sep 19 2024. Currency figures normalised to Biofrontera Inc's reporting currency: US Dollar USD
22.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rosalind Advisors, Inc.as of 30 Jun 2024 | 504.26k | 9.10% |
| AIGH Capital Management LLCas of 30 Jun 2024 | 501.43k | 9.05% |
| Scotia Capital, Inc. (Broker)as of 30 Jun 2024 | 120.00k | 2.17% |
| Matejka & Partner Asset Management GmbHas of 31 May 2024 | 63.80k | 1.15% |
| Geode Capital Management LLCas of 30 Jun 2024 | 17.54k | 0.32% |
| Tower Research Capital LLCas of 30 Jun 2024 | 10.49k | 0.19% |
| UBS Securities LLCas of 30 Jun 2024 | 10.02k | 0.18% |
| amandea Verm�gensverwaltung AGas of 31 Dec 2022 | 10.00k | 0.18% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 4.62k | 0.08% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 576.00 | 0.01% |
More ▼
Data from 31 May 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
